U
UBS Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
926
InMode
INMD
$972M
|
DA
Danielle Antalffy
| $15.38 | $16.25 |
6%
upside
| Neutral |
29 Apr ‘25
4 months ago |
|
927
McKesson
MCK
$90.2B
|
KC
Kevin Caliendo
| $725 | $805 |
11%
upside
| Buy |
29 Apr ‘25
4 months ago |
|
928
Cencora
COR
$58.6B
|
KC
Kevin Caliendo
| $302.20 | $335 |
11%
upside
| Buy |
29 Apr ‘25
4 months ago |
|
929
Kinetik
KNTK
$2.64B
|
MG
Manav Gupta
| $42.91 | $49 |
14%
upside
| Neutral |
29 Apr ‘25
4 months ago |
|
930
Saia
SAIA
$8.38B
|
TW
Thomas Wadewitz
| $314.73 | $305 |
3%
downside
| Buy |
28 Apr ‘25
4 months ago |
|
931
Booking.com
BKNG
$179B
|
LW
Lloyd Walmsley
| $5,523.42 | $5,557 |
1%
upside
| Buy |
28 Apr ‘25
4 months ago |
|
932
Harmony Biosciences
HRMY
$1.92B
|
AV
Ashwani Verma
| $33.45 | $48 |
44%
upside
| Buy |
28 Apr ‘25
4 months ago |
|
933
Evergy
EVRG
$16.5B
|
WA
William Appicelli
| $71.86 | $78 |
9%
upside
| Buy |
28 Apr ‘25
4 months ago |
|
934
Alphabet (Google) Class A
GOOGL
$2.9T
|
SJ
Stephen Ju
| $239.79 | $186 |
22%
downside
| Neutral |
25 Apr ‘25
4 months ago |
|
935
Coherus Oncology, Inc. Common Stock
CHRS
$151M
|
AV
Ashwani Verma
| $1.30 | $1.05 |
19%
downside
| Neutral |
24 Apr ‘25
4 months ago |
|
936
Masco
MAS
$15.7B
|
JL
John Lovallo
| $75.03 | $80 |
7%
upside
| Buy |
24 Apr ‘25
4 months ago |
|
937
Procore
PCOR
$10.6B
|
TM
Taylor McGinnis
| $70.56 | $87 |
23%
upside
| Buy |
24 Apr ‘25
4 months ago |
|
938
Align Technology
ALGN
$9.84B
|
KC
Kevin Caliendo
| $135.79 | $215 |
58%
upside
| Neutral |
24 Apr ‘25
4 months ago |
|
939
Healthcare Services Group
HCSG
$1.18B
|
AR
A.J. Rice
| $16.36 | $15 |
8%
downside
| Buy |
24 Apr ‘25
4 months ago |
|
940
Pentair
PNR
$18.4B
|
DK
Damian Karas
| $112.25 | $110 |
2%
downside
| Buy |
23 Apr ‘25
4 months ago |
|
941
Northrop Grumman
NOC
$83.4B
|
GP
Gavin Parsons
| $582.77 | $571 |
2%
downside
| Buy |
23 Apr ‘25
4 months ago |
|
942
Blackstone
BX
$145B
|
BH
Brennan Hawken
| $185.22 | $175 |
6%
downside
| Buy |
22 Apr ‘25
4 months ago |
|
943
Charles Schwab
SCHW
$170B
|
BH
Brennan Hawken
| $93.39 | $96 |
3%
upside
| Buy |
22 Apr ‘25
4 months ago |
|
944
Interactive Brokers
IBKR
$28.4B
|
BH
Brennan Hawken
| $63.77 | $50 |
22%
downside
| Buy |
22 Apr ‘25
4 months ago |
|
945
Immunovant
IMVT
$2.9B
|
CB
Colin Bristow
| $16.66 | $17 |
2%
upside
| Neutral |
22 Apr ‘25
4 months ago |
|
946
CSX Corp
CSX
$60.8B
|
TW
Thomas Wadewitz
| $32.60 | $34 |
4%
upside
| Buy |
17 Apr ‘25
4 months ago |
|
947
ChargePoint
CHPT
$242M
|
RJ
Robert Jamieson
| $10.37 | $13 |
25%
upside
| Neutral |
17 Apr ‘25
4 months ago |
|
948
Blink Charging
BLNK
$142M
|
WG
William Grippin
| $1.24 | $0.8000 |
35%
downside
| Neutral |
17 Apr ‘25
4 months ago |
|
949
JPMorgan Chase
JPM
$837B
|
EN
Erika Najarian
| $304.51 | $305 |
0%
upside
| Buy |
17 Apr ‘25
4 months ago |
|
950
Par Pacific Holdings
PARR
$1.71B
|
MG
Manav Gupta
| $33.75 | $14.75 |
56%
downside
| Neutral |
16 Apr ‘25
4 months ago |
|